Chaperone + RhIDUA Enzyme Replacement Therapy (Amicus Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameChaperone + RhIDUA Enzyme Replacement Therapy (Amicus Therapeutics)

Drug Alias NameChaperone + IDUA Enzyme Replacement Therapy (Amicus Therapeutics)Chaperone + Recombinant Alpha-L-Iduronidase Enzyme Replacement Therapy (Amicus Therapeutics)rhIDUA biobetter

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionAlpha-L-iduronidase stimulants

TargetsAlpha-L-iduronidase

Therapy Area/IndicationsMucopolysaccharidosis I

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmicus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmicus Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsMucopolysaccharidosis I

Other Information

ATC CodeN/A